Nice Ltd (NICE.OQ)
21 Sep 2018
Tue, Aug 28 2018
LONDON, Aug 28 A cutting-edge CAR-T cell therapy for otherwise untreatable forms of blood cancer is too expensive to justify its use on Britain's state-funded health service, the country's healthcare cost agency NICE said on Tuesday.
TEL AVIV, Aug 9 Israeli software provider Nice beat second-quarter profit forecasts on Thursday and raised its full-year earnings forecast by 3 cents a share, bolstered by its cloud and analytics tools.
* NICE REPORTS 10% REVENUE GROWTH FOR THE FIRST QUARTER 2018 ALONG WITH 32% GROWTH IN CLOUD REVENUE
* NICE TO ACQUIRE MATTERSIGHT, BOLSTERING ITS LEADERSHIP IN CLOUD CUSTOMER SERVICE ANALYTICS
- NICE-Systems' (NICE) CEO Barak Eilam on Q2 2018 Results - Earnings Call Transcript
- Illinois Tool Works Is Doing Better Than The Stock Indicates - Cramer's Lightning Round (7/17/18)
- Game Plan For The Week - Cramer's Mad Money (5/11/18)
- NICE-Systems' (NICE) CEO Barak Eilam on Q1 2018 Results - Earnings Call Transcript
- IBEX Holdings Updates U.S. IPO Terms
- IBEX Holdings Files For $75 Million U.S. IPO